Zhihang Shen received her Ph.D. in Medicinal Chemistry from the University of Florida in 2025 and is currently a postdoctoral associate at Calibr-Skaggs for Innovative Medicine from Scripps Institute. She worked as a graduate assistant at the University of Florida (2020–2025). In 2025, she joined Calibr and began focusing on translational research in drug discovery. Her research topics mainly include biophysical assay development, protein–ligand interaction profiling, PRMT5-targeted drug discovery, and AI-assisted virtual screening.
Zhihang Shen received her Ph.D. in Medicinal Chemistry from the University of Florida in 2025 and is currently a postdoctoral associate at Calibr-Skaggs for Innovative Medicine from Scripps Institute. She worked as a graduate assistant at the University of Florida (2020–2025). In 2025, she joined Calibr and began focusing on translational research in drug discovery. Her research topics mainly include biophysical assay development, protein–ligand interaction profiling, PRMT5-targeted drug discovery, and AI-assisted virtual screening.